Walbrook Public Relations

Financial Public Relations and Investor Relations

Investor Login

+44 (0)20 7933 8780   ●   info@walbrookpr.com

Walbrook is a full service Financial Public Relations and Investor Relations consultancy that has a strong reputation for advising growing Small Cap and AIM listed companies.

Our clients range from £2m market capitalisation to £200m across a wide number of sectors.

"Competition for investor, analyst and media attention is strong, so awareness and understanding of your company amongst these audiences will be key to a successful investor relations strategy."

Latest News

Walbrook PR appointed as financial PR to SyQic plc

8 September 2014 Read More »

Walbrook PR appointed as financial PR to Optibiotix Health plc

4 August 2014 Read More »

Walbrook PR appointed as financial PR to EMED Mining

8 July 2014 Read More »

Walbrook PR appointed as financial PR to ACTA S.P.A

25 June 2014 Read More »

Latest Transaction

opti

Company Details

Company Name
Optibiotix Health Plc
FTSE sector
Pharmaceuticals & Biotechnology
Transaction Date
5 August 2014
Description

OptiBiotix Health plc (AIM: OPTI), announces its admission to trading on AIM.

CDOGlogo

Company Details

Company Name
CDialogues Plc
FTSE sector
Media
Transaction Date
27 June 2014
Description

Admission to AIM of mobile marketing Company, CDialogues, and placing to raise £1.25m

Company Details

Company Name
ULS Technology Plc
FTSE sector
Media
Transaction Date
28 July 2014
Description

ULS Technology Group plc is pleased to announce its admission to trading on AIM.

Expertise

dummy_expertise

Our primary objective is to increase the public profile of our clients resulting in increased knowledge and interest among investors and their advisers within the City and the international financial community.

To achieve our clients’ goals we address four interlinked audiences:


Read More »